VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
APLSApellis Pharmaceuticals, Inc.
$41.03$5.3B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAPLSPrice History

APLS logoApellis Pharmaceuticals, Inc. (APLS) Stock Price History

Historical prices from 2017 to 2026

$41.03+0.00  (+0.00%)close May 15
Returns
1M
—
3M
+129.3%
YTD
+58.7%
1Y
+131.0%
3Y
-22.5%
5Y
-7.4%
ATH$94.75Jun 2023-56.7%
ATL$11.45Oct 2018pre-split
Avg Vol (50D)6.7M/ day
52-Week Range$16.83 — $41.12
LowCurrent: $41.03High

Loading 10-year price history...

APLS Historical Performance

1 YearTotal Return
+131.0%
Price: +131.0%
3 YearsTotal Return
-53.5%
CAGR: -22.5%
Price: -53.5%
5 YearsTotal Return
-31.7%
CAGR: -7.4%
Price: -31.7%
YTD
+58.7%

APLS Annual Returns

Year-by-year price performance · 2017–2026

Best+124.8%2019
Worst-47.9%2024
Up years5/10
2017+54.7%
2018-36.5%
2019+124.8%
2020+83.5%
2021-13.4%
2022+6.0%
2023+19.1%
2024-47.9%
2025-24.2%
2026-18.9%
2017 annual price return
+54.7%
2018 annual price return
-36.5%
2019 annual price return
+124.8%
2020 annual price return
+83.5%
2021 annual price return
-13.4%
2022 annual price return
+6.0%
2023 annual price return
+19.1%
2024 annual price return
-47.9%
2025 annual price return
-24.2%
2026 annual price return
-18.9%
LessMore
Alpha vs S&P 500
1Y+106.0%
3Y-42.0%
5Y-19.7%

Price returns only.

Download Historical Data

2,140 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

APLS Stock Price Trajectory (2017–2026)

As of June 23, 2026, Apellis Pharmaceuticals, Inc. (APLS) trades at $41.03, representing a +131.0% return over the past year. The stock has delivered a -31.7% total return over five years (-7.4% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $94.75 on June 14, 2023. From this peak, APLS has corrected -56.7%, currently trading 57% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers RARE (-26.5% 1Y), BEAM (+100.9% 1Y), and AKRO (-0.5% 1Y), APLS has outperformed the peer group average. Compare APLS vs RARE →

APLS Historical Price Data · from 2017

Rows 1–50 of 2,140
Date Open High Low Close Volume Change %
2026-05-1541.0541.0541.0341.0328.64M0.00%
2026-05-1441.0341.0341.0341.0300.00%
2026-05-1341.0541.0741.0341.0355.80M-0.07%
2026-05-1241.0341.0741.0341.066.33M+0.10%
2026-05-1141.0341.0641.0241.027.44M-0.05%
2026-05-0841.0241.0541.0041.045.00M+0.07%
2026-05-0740.9841.0740.9841.016.31M-0.27%
2026-05-0641.0541.1240.9541.123.71M+0.37%
2026-05-0540.9540.9940.9340.972.78M0.00%
2026-05-0440.9640.9740.9540.972.51M+0.02%
2026-05-0140.9540.9740.9440.961.68M+0.02%
2026-04-3040.9540.9640.9340.951.58M0.00%
2026-04-2940.9540.9740.9340.952.55M-0.10%
2026-04-2840.9441.0040.9340.993.75M+0.10%
2026-04-2740.9340.9540.9140.952.75M+0.02%
2026-04-2440.9440.9940.9040.941.91M0.00%
2026-04-2340.9140.9440.8740.942.76M+0.12%
2026-04-2240.9240.9440.8840.892.13M-0.12%
2026-04-2140.9240.9440.8840.944.06M0.00%
2026-04-2040.8840.9440.8640.944.09M+0.10%
2026-04-1740.8640.9540.8540.905.19M+0.07%
2026-04-1640.8440.9040.8040.875.18M+0.06%
2026-04-1540.8440.8840.8340.842.44M-0.01%
2026-04-1440.8340.8840.7840.853.99M+0.02%
2026-04-1340.7340.8740.7040.845.82M+0.12%
2026-04-1040.6840.7940.6540.796.74M+0.34%
2026-04-0940.7340.7640.6440.656.50M-0.10%
2026-04-0840.6640.7340.6540.694.53M-0.02%
2026-04-0740.6140.7740.6040.704.28M+0.17%
2026-04-0640.4340.6940.4140.635.80M+0.54%
2026-04-0240.3740.4840.3540.4110.33M+0.05%
2026-04-0140.3540.4240.3240.3928.29M+0.40%
2026-03-3140.3940.4540.2340.2389.85M+135.40%
2026-03-3016.9817.2716.8317.092.15M+0.71%
2026-03-2717.5517.6116.9716.971.75M-3.80%
2026-03-2617.6217.9817.4817.641.66M-0.45%
2026-03-2517.4417.9617.3917.721.77M+2.84%
2026-03-2417.4617.4616.8417.232.09M-1.94%
2026-03-2317.6017.9417.3217.572.40M+2.09%
2026-03-2017.8418.0917.1617.214.80M-4.23%
2026-03-1917.8918.0117.5717.972.32M+0.45%
2026-03-1818.4318.5917.4317.895.24M-4.94%
2026-03-1718.9519.3218.7318.821.34M-0.26%
2026-03-1619.1019.3118.7718.871.32M-0.37%
2026-03-1318.8419.0518.4218.941.71M+2.99%
2026-03-1219.2619.2618.3418.392.60M-5.11%
2026-03-1119.4319.4918.9819.381.63M-1.32%
2026-03-1019.8919.8919.4119.641.26M-1.75%
2026-03-0920.0020.2019.3419.991.46M-0.40%
2026-03-0620.1020.3919.7620.071.60M-0.40%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

APLS — Frequently Asked Questions

Quick answers to the most common questions about buying APLS stock.

How has APLS stock performed recently?

APLS returned +131.0% over the past year, beating its 5-year annualized CAGR of -7.4%. The stock trades above its 200-day moving average, confirming the uptrend.

What is APLS's all-time high price?

Apellis Pharmaceuticals, Inc. reached $94.75 on 2023-06-14. The 52-week high is $41.12. Current 1-year return of +131.0% places the stock closer to historical peaks.

Where can I download APLS historical price data?

This page provides APLS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2017-2026, downloadable in CSV format.

429 data points · sampled from 2,140